Australia markets open in 9 hours 13 minutes

Twist Bioscience Corp (0ME.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
35.40+1.67 (+4.94%)
As of 04:18PM CEST. Market open.
Full screen
Previous close33.74
Bid35.31 x 280000
Ask35.91 x 190000
Day's range35.40 - 35.58
52-week range23.83 - 118.60
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    3 Monster Stocks in the Making

    Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Exelixis (NASDAQ: EXEL), and Twist Bioscience (NASDAQ: TWST). Prosper Junior Bakiny (Axsome Therapeutics): Many qualities are necessary to be a successful investor. The case of Axsome Therapeutics somewhat illustrates that.

  • Business Wire

    The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia

    SOUTH SAN FRANCISCO, Calif. & SYDNEY, September 20, 2022--Twist Bioscience (Nasdaq: TWST) and the Australian Research Council (ARC) Centre of Excellence in Synthetic Biology (CoESB) today announced a partnership that will enable CoESB members and partners to order a wide range of Twist products that facilitate research and development.

  • Business Wire

    Twist Bioscience to Present at Baird 2022 Global Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., September 06, 2022--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience will present at the Baird 2022 Global Healthcare Conference on Tuesday, September 13th, at 2:35 p.m. Eastern Time in New York, NY.